Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of Org 50081 (esmirtazapine) in elderly outpatients with chronic primary insomnia
2007-003636-35Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of esmirtazapine in Insomnia (2 arms), sponsored by Organon & Co. Primary endpoint: Primary: Safety and tolerability of long-term Org 50081 treatment. Started Sep 2007; status: completed.
02
Drugs
esmirtazapine
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2007-003636-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003636-35.